Search hospitals > Massachusetts > Gloucester

Addison Gilbert Hospital

Claim this profile
Gloucester, Massachusetts 01930
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
95 reported clinical trials
9 medical researchers
Photo of Addison Gilbert Hospital in GloucesterPhoto of Addison Gilbert Hospital in GloucesterPhoto of Addison Gilbert Hospital in Gloucester

Summary

Addison Gilbert Hospital is a medical facility located in Gloucester, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Addison Gilbert Hospital is involved with conducting 95 clinical trials across 139 conditions. There are 9 research doctors associated with this hospital, such as Corrine Zarwan, MD, Brendan Connell, Paul J. Hesketh, and Andrew Piper-Vallillo.

Area of expertise

1Cancer
Global Leader
Addison Gilbert Hospital has run 39 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Addison Gilbert Hospital has run 37 trials for Breast Cancer. Some of their research focus areas include:
ER positive
PR positive
HER2 negative

Top PIs

Clinical Trials running at Addison Gilbert Hospital

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Carcinoma
Recurrence
ALK Gene Rearrangement
Squamous Cell Carcinoma
Colorectal Cancer
Prostate Adenocarcinoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Symptom Monitoring

for Young Women on Hormone Therapy

This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Addison Gilbert Hospital?
Addison Gilbert Hospital is a medical facility located in Gloucester, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Addison Gilbert Hospital is involved with conducting 95 clinical trials across 139 conditions. There are 9 research doctors associated with this hospital, such as Corrine Zarwan, MD, Brendan Connell, Paul J. Hesketh, and Andrew Piper-Vallillo.